Indegene helped a top-5 biopharma company scale dossier submissions by 50x for its hepatitis and respiratory brands, expanding coverage to China's Community Health Centers and county hospitals in dispersed Tier-1 cities amid sales losses from coverage gaps and rising rep deployment costs with shrinking budgets. Challenges included reaching vastly spread doctors in smaller cities. Indegene's software automated and streamlined submission processes from 700 across 11 markets to massive scalability, slashing costs, boosting efficiency, and unlocking market access for sustained revenue growth.

Join for free to read